52 BozzaliM.DAmelioM.SerraL
Secondary analyses of these studies suggested that weight loss might be the main driver of GLP-1RA efficacy in MASH, supported by the lack of expression of GLP-1 receptors in the human liver 93
This approach aligns with the growing trend of consumer-driven health management, driven by increased access to medical information and the expansion of telemedicine, Isman explains
I would like to thank Paris Rich Bingham and Sebastian Butts for research assistance, and Rasa Siniakovas and Chris Miller for editorial assistance
10.1007/s00011-025-01994-w 114 IranpourS.BahramiA
Kim KS, Lee YH, Yun JW, Kim YB, Song HY, Park JS, et al